Nagaizumicho
Nagaizumicho
Nagaizumicho, Shizuoka, Japan1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. | neoplasm, refractory malignant neoplasm | Recruiting | Phase 1 | 2025-06-12 | NCT07016997 |